Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
Open Access
Abstract
Cancer remains a major public health issue and a leading cause of death worldwide. Despite advancements in chemotherapy, radiation therapy, and immunotherapy, surgery is the mainstay of cancer treatment for solid tumors. However, tumor cells are known to disseminate into the vascular and lymphatic systems during surgical manipulation. Additionally, surgery-induced stress responses can produce an immunosuppressive environment that is favorable for cancer relapse. Up to 90% of cancer-related deaths are the result of metastatic disease after surgical resection. Emerging evidence shows that the interactions between tumor cells and the tumor microenvironment (TME) not only play decisive roles in tumor initiation, progression, and metastasis but also have profound effects on therapeutic efficacy. Tumor necrosis factor alpha (TNF-α), a pleiotropic cytokine contributing to both physiological and pathological processes, is one of the main mediators of inflammation-associated carcinogenesis in the TME. Because TNF-α signaling may modulate the course of cancer, it can be therapeutically targeted to ameliorate clinical outcomes. As the incidence of cancer continues to grow, approximately 80% of cancer patients require anesthesia during cancer care for diagnostic, therapeutic, or palliative procedures, and over 60% of cancer patients receive anesthesia for primary surgical resection. Numerous studies have demonstrated that perioperative management, including surgical manipulation, anesthetics/analgesics, and other supportive care, may alter the TME and cancer progression by affecting inflammatory or immune responses during cancer surgery, but the literature about the impact of anesthesia on the TNF-α production and cancer progression is limited. Therefore, this review summarizes the current knowledge of the implications of anesthesia on cancers from the insights of TNF-α release and provides future anesthetic strategies for improving oncological survival.Keywords
This publication has 227 references indexed in Scilit:
- Hypothermia Activates Adipose Tissue to Promote Malignant Lung Cancer ProgressionPLOS ONE, 2013
- Effects of sevoflurane and propofol on the inflammatory response and pulmonary function of perioperative patients with one-lung ventilationExperimental and Therapeutic Medicine, 2013
- Non-Steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer CellsPLOS ONE, 2013
- Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2Journal of Experimental & Clinical Cancer Research, 2012
- Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectumOncology Reports, 2012
- Accumulation of Pro-Cancer Cytokines in the Plasma Fraction of Stored Packed Red CellsJournal of Gastrointestinal Surgery, 2012
- Volatile Anesthetics Protect Cancer Cells against Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis via CaveolinsAnesthesiology, 2011
- Tumor necrosis factor and cancer, buddies or foes?Acta Pharmacologica Sinica, 2008
- Systemic Lidocaine Shortens Length of Hospital Stay After Colorectal SurgeryAnnals of Surgery, 2007
- The opioid antagonist, β-funaltrexamine, inhibits chemokine expression in human astroglial cellsJournal of Neuroimmunology, 2007